The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population
Abstract
The Chennai Urban Population Study investigates a South Indian population with a high prevalence of cardiovascular disease associated with the metabolic syndrome (MS). The Ala54Thr polymorphism in the fatty acid-binding protein 2 (FABP2) gene as well as the T-455C and C-482T polymorphisms in the apolipoprotein C-III (APOC3) gene promoter have been associated with features of the MS in specific populations. This study evaluates in Asian-Indians the association between these polymorphisms with MS and dyslipidemia, defined according to National Cholesterol Education Program Adult Treatment Panel III. Allelic frequencies in 70 controls and 110 patients with diabetes from the Chennai Urban Population Study were 52.9% for FABP2 Thr54, 73.0% for APOC3 -482T, and 80.2% for APOC3 -455C. The polymorphisms were in agreement with Hardy-Weinberg equilibrium. Controls carrying FABP2 Thr54 were more likely to have MS than noncarriers (Fisher's exact test P = 0.031; odds ratio = 6.9 with a 95% confidence interval of 1.1, 43.9). Those carrying at least one polymorphic allele in both genes had a higher likelihood of having MS than wild type (Fisher's exact test P = 0.003; odds ratio = 12.1 with a 95% confidence interval of 1.88, 77.6). Dyslipidemia was associated with the polymorphism as well. The polymorphisms were not associated with MS in patients with diabetes. The association of the polymorphisms with MS and dyslipidemia could contribute to the high cardiovascular disease prevalence in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have suggested that two single-nucleotide polymorphisms (SNPs) in the gene encoding apolipoprotein C3 (APOC3) may be associated with hypertriglyceridemia.4–8”
From Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease (2010) · cites this paper as [7]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618
Anand, S. S., Yusuf, S., Vuksan, V., Devanesen, S., Teo, K. K., Montague, P. A., Kelemen, L. E., Yi, C., Lonn, E., Gerstein, H. C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02502-2 · Cited by 1,060
Balarajan, R. (1991) · BMJ · doi:10.1136/bmj.302.6776.560 · Cited by 484
Baier, L. J., Sacchettini, J. C., Knowler, W. C., Eads, J. C., Paolisso, G., Tataranni, P. A., Mochizuki, H., Bennett, P. H., Bogardus, C., & Procházka, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117778 · Cited by 371
Mohan, V., Deepa, R., Rani, S. S., & Premalatha, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01415-2 · Cited by 365
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–108 of 108
Pollex, R. L., & Hegele, R. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-369420-1.00097-4
Ahmed, R. (2021) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2021.33330
(2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.75
Atherosclerotic Cardiovascular Disease in South Asians: Epidemiology, Risk Factors, and Management
Gera, P., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001144
Harun, N. S., Jusoh, A. F. W., Rohin, M. A. K., Yahaya, R., Nik Him, N. A. S., & Zahary, M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26603314
Harun, N. S., Jusoh, A. F. W., Rohin, M. A. K., Yahaya, R., Nik Him, N. A. S., & Zahary, M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26603326
Harun, N. S., Jusoh, A. F. W., Rohin, M. A. K., Yahaya, R., Nik Him, N. A. S., & Zahary, M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26603317
Harun, N. S., Jusoh, A. F. W., Rohin, M. A. K., Yahaya, R., Nik Him, N. A. S., & Zahary, M. N. (2024) · Figshare · doi:10.6084/m9.figshare.26603320
Metadata
- Authors
- Guettier, J.-M., Georgopoulos, A., Tsai, M. Y., Radha, V., Shanthirani, S., Deepa, R., Gross, M., Rao, G., & Mohan, V.
- Affiliations
- University of Minnesota (US)
- Madras Diabetes Research Foundation (IN)
- Corresponding author
- Georgopoulos, Angeliki
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 90
- Issue
- 3
- Pages
- 1705-1711
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2085689054
- Cited by
- 108
- References
- 49
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 5 · 2017: 7 · 2016: 5 · 2014: 11 · 2013: 3 · 2012: 1
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- fatty acid binding protein 2, apolipoprotein C-III, metabolic syndrome, dyslipidemia, Asian Indians, South Indian population, diabetes mellitus, cardiovascular disease, genetic susceptibility
- MeSH terms
- Adult, Aged, Apolipoproteins C, Carrier Proteins, Female, Gene Frequency, Humans, Hyperlipidemias, India, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, Risk Factors, Prevalence, Genetic Predisposition to Disease, Metabolic Syndrome, Asian People, Fatty Acid-Binding Proteins, Apolipoprotein C-III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
